Key details
Sponsor
Zhejiang University
Collaborators
YolTech Therapeutics Co., Ltd
Enrollment target
~7 participants
Primary completion
July 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 80 Years
Last updated February 2025